| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10232372 | Current Opinion in Biotechnology | 2005 | 5 Pages |
Abstract
In recent years multiple reports indicating that embryonic as well as adult stem cells can differentiate to cardiomyocytes have ignited discussions on whether these stem cells could lead to new therapies for patients with heart disease. Recent developments have been made in the generation of cardiomyocytes from both embryonic and adult stem cells, and progress towards clinical applications in patients with heart failure has been made. Nevertheless, controversies surrounding safety and transdifferentiation issues will need to be overcome before these stem cell approaches can reach their full potential.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Robert Passier, Christine Mummery,